Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

50%

4 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 4

3(42.9%)

Phase 3

1(14.3%)

7Total

N/A(3)

Phase 4(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06787274Recruiting

Research on Equity in Abortion Care by TeleHealth

Role: collaborator

NCT07174856Phase 4Not Yet Recruiting

The Misoprostol-Only Regimen Evidence Study

Role: lead

NCT04181021Not ApplicableCompleted

Evaluation of Values Clarification and Attitude Transformation Workshops on Abortion and Family Planning Service Provision and Client Experience

Role: lead

NCT00129506Phase 4Completed

Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion

Role: collaborator

NCT02745093Phase 4Unknown

Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks

Role: lead

NCT00121459Phase 3Withdrawn

Effectiveness of the Diaphragm for HIV Prevention

Role: collaborator

NCT01001507Not ApplicableCompleted

Integrating Family Planning Services Into HIV Care and Treatment in Nyanza Province, Kenya

Role: collaborator

NCT01597726Not ApplicableCompleted

Cervical Priming Before Dilation & Evacuation

Role: lead

All 8 trials loaded